152 related articles for article (PubMed ID: 36384721)
1. Progress on research and development in diabetes mellitus.
Zhang LW; Ruan MH; Liu JL; He CH; Yu JR
Yi Chuan; 2022 Oct; 44(10):824-839. PubMed ID: 36384721
[TBL] [Abstract][Full Text] [Related]
2. China's new drug R&D is steadily advancing.
Xu WF
Drug Discov Ther; 2007 Aug; 1(1):3. PubMed ID: 22504356
[TBL] [Abstract][Full Text] [Related]
3. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
4. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
5. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
[TBL] [Abstract][Full Text] [Related]
6. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
7. How Technological Innovation Affect China's Pharmaceutical Smart Manufacturing Industrial Upgrading.
Wang S; Chen Y
J Healthc Eng; 2021; 2021():3342153. PubMed ID: 34868514
[TBL] [Abstract][Full Text] [Related]
8. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D insufficiency and diabetes risks.
Boucher BJ
Curr Drug Targets; 2011 Jan; 12(1):61-87. PubMed ID: 20795936
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clinical trials of new drugs in China as of 2019.
Lin L; Chen Y; Yan L; Liu Y; Ni J; Yang H; Li H
Drug Discov Today; 2020 Dec; 25(12):2080-2088. PubMed ID: 33017690
[TBL] [Abstract][Full Text] [Related]
11. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
Holt RIG; Gossage-Worrall R; Hind D; Bradburn MJ; McCrone P; Morris T; Edwardson C; Barnard K; Carey ME; Davies MJ; Dickens CM; Doherty Y; Etherington A; French P; Gaughran F; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Saxon D; Shiers D; Siddiqi N; Swaby EA; Waller G; Wright S
Br J Psychiatry; 2019 Feb; 214(2):63-73. PubMed ID: 30251622
[TBL] [Abstract][Full Text] [Related]
12. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
[TBL] [Abstract][Full Text] [Related]
13. Comparison of external R&D and internal R&D: Based on the perspective of S&T development of China's pharmaceutical manufacturing industry.
Wu D; Wang S; Chang S; Lian G; Chen Y
PLoS One; 2022; 17(6):e0270271. PubMed ID: 35731793
[TBL] [Abstract][Full Text] [Related]
14. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
[TBL] [Abstract][Full Text] [Related]
15. Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus.
Kaur P; Mittal A; Nayak SK; Vyas M; Mishra V; Khatik GL
Curr Drug Targets; 2018; 19(15):1738-1766. PubMed ID: 30051787
[TBL] [Abstract][Full Text] [Related]
16. Advances in FGFs for diabetes care applications.
Liu Y; Chen Q; Li Y; Bi L; He Z; Shao C; Jin L; Peng R; Zhang X
Life Sci; 2022 Dec; 310():121015. PubMed ID: 36179818
[TBL] [Abstract][Full Text] [Related]
17. Financial aspects and the future of the pharmaceutical industry in the United States of america.
Karamehic J; Ridic O; Ridic G; Jukic T; Coric J; Subasic D; Panjeta M; Saban A; Zunic L; Masic I
Mater Sociomed; 2013 Dec; 25(4):286-90. PubMed ID: 24511277
[TBL] [Abstract][Full Text] [Related]
18. The development of Bio-pharmaceutical industry in China: problems and solutions.
Yan G
Pak J Pharm Sci; 2014 Jul; 27(4 Suppl):1035-9. PubMed ID: 25016263
[TBL] [Abstract][Full Text] [Related]
19. Current Status of the Health Information Technology Industry in China from the China Hospital Information Network Conference: Cross-sectional Study of Participating Companies.
Zhang Z; Zheng X; An K; He Y; Wang T; Zhou R; Zheng Q; Nuo M; Liang J; Lei J
JMIR Med Inform; 2022 Jan; 10(1):e33600. PubMed ID: 35014959
[TBL] [Abstract][Full Text] [Related]
20. To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers.
Leigh S; Noble ME; Pearson FE; Iremonger J; Williams DT
Pharmaceut Med; 2021 Nov; 35(6):353-365. PubMed ID: 34874534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
